{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:09:30Z","timestamp":1789348170124,"version":"build-2803163510"},"reference-count":180,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.jaad.2006.08.048","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T07:56:16Z","timestamp":1170748576000},"page":"651-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":403,"title":["Guidelines of care for acne vulgaris management"],"prefix":"10.1016","volume":"56","author":[{"given":"John S.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Krowchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Leyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Lucky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Shalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Beutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol K.","family":"Sieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reva","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.08.048_bib1","first-page":"111","article-title":"Simplifying the language of evidence to improve patient care: Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in medical literature","volume":"53","author":"Ebell","year":"2004","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2006.08.048_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mjd.2002.120912","article-title":"Acne therapy: a methodologic review","volume":"47","author":"Lehmann","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0190-9622(08)80076-X","article-title":"Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990","volume":"24","author":"Pochi","year":"1991","journal-title":"J Am\u00a0Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-4362.1997.00099.x","article-title":"A comparison of current acne grading systems and proposal of a novel system","volume":"36","author":"Doshi","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1982.01650130027012","article-title":"Various parameters for grading acne vulgaris","volume":"118","author":"Allen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0190-9622(96)90680-5","article-title":"A multirater validation study to assess the reliability of acne lesion counting","volume":"35","author":"Lucky","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1979.04010050005003","article-title":"An acne grading method using photographic standards","volume":"115","author":"Cook","year":"1979","journal-title":"Arch Dermatol"},{"issue":"suppl 27","key":"10.1016\/j.jaad.2006.08.048_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2133.1984.tb15598.x","article-title":"Assessing inflammatory acne vulgaris\u2014correlation between clinical and photographic methods","volume":"111","author":"Gibson","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1984.tb04020.x","article-title":"The assessment of acne vulgaris\u2014the Leeds technique","volume":"111","author":"Burke","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2230.1992.tb02521.x","article-title":"Practical use of a disability index in the\u00a0routine management of acne","volume":"17","author":"Motley","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib11","first-page":"942","article-title":"The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2230.2001.00839.x","article-title":"Health-related quality of life among patients with facial acne\u2014assessment of a new acne-specific questionnaire","volume":"26","author":"Martin","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archderm.134.4.454","article-title":"Acne vulgaris and the quality of life of adult dermatology patients","volume":"134","author":"Lasek","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib14","first-page":"672","article-title":"The quality of life in acne: a comparison with general medical conditions using generic questionnaires","volume":"140","author":"Mallon","year":"1999","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/000155598442773","article-title":"The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris","volume":"78","author":"Gupta","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.08.048_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2133.1980.tb08140.x","article-title":"Acne vulgaris: is the bacterial population size significant?","volume":"102","author":"Cove","year":"1980","journal-title":"Br J Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2006.08.048_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003495-199500492-00027","article-title":"Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin","volume":"49","author":"Bojar","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2006.08.048_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.1989.tb01399.x","article-title":"Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure","volume":"121","author":"Eady","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","article-title":"Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1981.tb02752.x","article-title":"Reduced sex hormone binding globulin and derived free testosterone levels in women with severe acne","volume":"15","author":"Lawrence","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaad.2006.08.048_bib21","first-page":"675","article-title":"Most women with acne have polycystic ovaries","volume":"121","author":"Bunker","year":"1989","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2006.08.048_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1346-8138.1997.tb02778.x","article-title":"Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne","volume":"24","author":"Timpatanapong","year":"1997","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0031-3955(16)34397-8","article-title":"Endocrine aspects of acne","volume":"30","author":"Lucky","year":"1983","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaad.2006.08.048_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000251602","article-title":"Topical tretinoin, vitamin A acid (Airol) in\u00a0acne vulgaris. A controlled clinical trial","volume":"148","author":"Christiansen","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.08.048_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00007611-197406000-00014","article-title":"Topical application of vitamin A acid in acne vulgaris","volume":"67","author":"Bradford","year":"1974","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2006.08.048_bib27","first-page":"106","article-title":"Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris","volume":"216","author":"Krishnan","year":"1976","journal-title":"Practitioner"},{"key":"10.1016\/j.jaad.2006.08.048_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0190-9622(87)70200-X","article-title":"Efficacy of topical isotretinoin 0.05% gel\u00a0in\u00a0acne vulgaris: results of a multicenter, double-blind investigation","volume":"17","author":"Chalker","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0190-9622(96)90443-0","article-title":"A comparison of the efficacy and safety of adapalene gel\u00a00.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial","volume":"34","author":"Shalita","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib30","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/S0190-9622(97)70054-9","article-title":"Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients","volume":"36","author":"Clucas","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib31","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0190-9622(97)70056-2","article-title":"Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials","volume":"36","author":"Cunliffe","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 52","key":"10.1016\/j.jaad.2006.08.048_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2133.1998.1390s2017.x","article-title":"Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference","volume":"139","author":"Dunlap","year":"1998","journal-title":"Br J Dermatol"},{"issue":"suppl 52","key":"10.1016\/j.jaad.2006.08.048_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2133.1998.1390s2034.x","article-title":"Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations","volume":"139","author":"Galvin","year":"1998","journal-title":"Br J Dermatol"},{"issue":"suppl 52","key":"10.1016\/j.jaad.2006.08.048_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life","volume":"139","author":"Grosshans","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib35","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0190-9622(98)70140-9","article-title":"Irritation potential of a new topical tretinoin formulation and a commercially-available tretinoin formulation as measured by patch testing in human subjects","volume":"38","author":"Mills","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2133.2002.04873.x","article-title":"Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial","volume":"147","author":"Ioannides","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib37","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1067\/mjd.2000.108322","article-title":"Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris","volume":"43","author":"Kakita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib38","first-page":"349","article-title":"Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study","volume":"63","author":"Shalita","year":"1999","journal-title":"Cutis"},{"issue":"suppl 52","key":"10.1016\/j.jaad.2006.08.048_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2133.1998.1390s2041.x","article-title":"Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris","volume":"139","author":"Ellis","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl 6","key":"10.1016\/j.jaad.2006.08.048_bib40","first-page":"4","article-title":"Efficacy and tolerability of once-daily tazarotene 0.1% gel\u00a0versus once-daily tretinoin 0.025% gel in the treatment of\u00a0facial acne vulgaris: a randomized trial","volume":"67","author":"Webster","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib41","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0190-9622(98)70141-0","article-title":"Comparative efficacy and safety of two 0.025% tretinoin gels: results from\u00a0a multicenter double-blind, parallel study","volume":"38","author":"Lucky","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib42","first-page":"856","article-title":"Treatment of acne with 5% benzoyl peroxide gel or 0.05% retinoic acid cream","volume":"23","author":"Belknap","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1185\/03007997709110177","article-title":"Comparison of tretinoin solution and benzoyl peroxide lotion in the treatment of acne vulgaris","volume":"5","author":"Bucknall","year":"1977","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2006.08.048_bib44","first-page":"681","article-title":"Acne vulgaris: treatment with topical benzoyl peroxide acetone gel","volume":"19","author":"Montes","year":"1977","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2230.1992.tb00196.x","article-title":"A double-blind evaluation of\u00a0topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne","volume":"17","author":"Hughes","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib46","first-page":"479","article-title":"Benzoyl peroxide in acne","volume":"220","author":"Cunliffe","year":"1978","journal-title":"Practitioner"},{"key":"10.1016\/j.jaad.2006.08.048_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000249352","article-title":"Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris","volume":"172","author":"Fyrand","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.08.048_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.1982.tb00906.x","article-title":"The short-term effects of benzoyl peroxide lotion on the resolution of inflamed acne lesions","volume":"106","author":"Schutte","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-4362.1979.tb01955.x","article-title":"Benzoyl peroxide gel therapy in acne in Singapore","volume":"18","author":"Yong","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib50","first-page":"90","article-title":"Benzoyl peroxide lotion (20 percent) in acne","volume":"25","author":"Smith","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib51","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-4362.1986.tb04534.x","article-title":"Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris","volume":"25","author":"Mills","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0190-9622(80)80044-2","article-title":"Topically applied erythromycin in\u00a0inflammatory acne vulgaris","volume":"2","author":"Bernstein","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archderm.1981.01650090033020","article-title":"Topical erythromycin vs blank vehicle in a multiclinic acne study","volume":"117","author":"Jones","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib54","first-page":"372","article-title":"Clinical trial of topical erythromycin in inflammatory acne","volume":"15","author":"Prince","year":"1981","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jaad.2006.08.048_bib55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0190-9622(85)70074-6","article-title":"An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris","volume":"12","author":"Lesher","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib56","first-page":"132","article-title":"Erythromycin 2 percent gel in the treatment of acne vulgaris","volume":"41","author":"Pochi","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(80)80113-7","article-title":"Topical erythromycin solution in acne. Results of a multiclinic trial","volume":"3","author":"Dobson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three\u00a0months of topical acne therapy with 2% erythromycin\u00a0gel versus its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.08.048_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-4362.1981.tb02013.x","article-title":"Topical tetracycline hydrochloride vs. topical clindamycin phosphate in the treatment of acne: a comparative study","volume":"20","author":"Padilla","year":"1981","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib60","first-page":"624","article-title":"Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris","volume":"29","author":"Thomas","year":"1982","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1984.01650390073015","article-title":"Topical erythromycin vs clindamycin therapy for acne. A multicenter, double-blind comparison","volume":"120","author":"Shalita","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0190-9622(87)70107-8","article-title":"Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris","volume":"16","author":"Leyden","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archderm.1981.01650100032023","article-title":"Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation","volume":"117","author":"McKenzie","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib64","first-page":"203","article-title":"A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris","volume":"38","author":"Kuhlman","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib65","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.1981.01650080036024","article-title":"Topical clindamycin therapy for acne vulgaris. A cooperative clinical study","volume":"117","author":"Becker","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib66","first-page":"245","article-title":"A\u00a0comparison of Cleocin T Solution, Cleocin T Gel, and placebo\u00a0in the treatment of acne vulgaris","volume":"42","author":"Ellis","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000018255","article-title":"A\u00a0placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris","volume":"199","author":"Glass","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.048_bib68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/0001555558555557","article-title":"Treatment of acne vulgaris with topically applied erythromycin and tretinoin","volume":"58","author":"Mills","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.08.048_bib69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/09546639809161377","article-title":"Efficacy of a fixed clindamycin phosphate 1.2%, tretinoin 0.025% gel formulation (Velac) in the topical control of facial acne lesions","volume":"9","author":"Richter","year":"1998","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2006.08.048_bib70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2000.03701.x","article-title":"A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate\/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris","volume":"143","author":"Zouboulis","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-4362.1983.tb02113.x","article-title":"Clindamycin phosphate used in combination with tretinoin in the treatment of acne","volume":"22","author":"Rietschel","year":"1983","journal-title":"Int J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib72","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0190-9622(83)70211-2","article-title":"A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris","volume":"9","author":"Chalker","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib73","first-page":"165","article-title":"A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris","volume":"67","author":"Tschen","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/120347540100500109","article-title":"The\u00a0efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product","volume":"5","author":"Leyden","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2006.08.048_bib75","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib76","first-page":"556","article-title":"Treatment of mild and moderate acne vulgaris with salicylic acid in an alcohol-detergent vehicle","volume":"28","author":"Shalita","year":"1981","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib77","first-page":"31","article-title":"Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne","volume":"143","author":"Cunliffe","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jaad.2006.08.048_bib78","first-page":"35","article-title":"Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin","volume":"143","author":"Katsambas","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jaad.2006.08.048_bib79","first-page":"45","article-title":"Azelaic acid for the treatment of acne. A\u00a0clinical comparison with oral tetracycline","volume":"143","author":"Hjorth","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jaad.2006.08.048_bib80","first-page":"468","article-title":"Topical deodorized polysulfides. Broadscope acne therapy","volume":"28","author":"Elstein","year":"1981","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib81","first-page":"696","article-title":"Special topical approach to the treatment of acne. Suppression of sweating with aluminum\u00a0chloride in an anhydrous formulation","volume":"22","author":"Hurley","year":"1978","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib82","first-page":"499","article-title":"Topical anhydrous aluminum chloride formulation in the treatment of acne vulgaris: a\u00a0double-blind study","volume":"35","author":"Hjorth","year":"1985","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib83","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-4362.1985.tb05756.x","article-title":"Topical zinc therapy for acne vulgaris","volume":"24","author":"Cochran","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09546639309080548","article-title":"A single-blind comparison of topical erythromycin\/zinc lotion and oral minocycline in the treatment of acne vulgaris","volume":"4","author":"Stainforth","year":"1993","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jaad.2006.08.048_bib85","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1994.tb02929.x","article-title":"Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc","volume":"130","author":"Bojar","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archfami.9.2.179","article-title":"New treatments and therapeutic strategies for acne","volume":"9","author":"Thiboutot","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.jaad.2006.08.048_bib87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1540-9740.2004.03465.x","article-title":"Rosac cream with sunscreens (sodium sulfacetamide 10% and sulfur 5%)","volume":"3","author":"Lebrun","year":"2004","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2006.08.048_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2710.1997.9975099.x","article-title":"Topical sodium sulfacetamide\/sulfur lotion","volume":"22","author":"Tarimci","year":"1997","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaad.2006.08.048_bib89","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmj.2.5649.76","article-title":"Treatment of acne vulgaris with tetracycline hydrochloride: a double-blind trial with 51 patients","volume":"2","author":"Lane","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2006.08.048_bib90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00007611-197606000-00007","article-title":"The effectiveness of topical\u00a0and oral tetracycline for acne","volume":"69","author":"Smith","year":"1976","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2006.08.048_bib91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0190-9622(82)80009-1","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of acne.\u00a0Results\u00a0of a multiclinic trial","volume":"7","author":"Gratton","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.1987.tb05853.x","article-title":"Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris","volume":"116","author":"Katsambas","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib93","first-page":"71","article-title":"Topical clindamycin versus oral tetracycline and\u00a0placebo in acne vulgaris","volume":"43","author":"Braathen","year":"1984","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.jaad.2006.08.048_bib94","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/1523-1747.ep12481914","article-title":"The effect of oral and topical tetracycline on acne severity and on surface lipid composition","volume":"66","author":"Anderson","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archderm.1976.01630310033006","article-title":"Topical use of tetracycline in the treatment of acne: a double-blind study comparing topical and oral tetracycline therapy and placebo","volume":"112","author":"Blaney","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib96","first-page":"122","article-title":"Evaluation of topical erythromycin and oral tetracycline in acne vulgaris","volume":"30","author":"Rapaport","year":"1982","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib97","first-page":"31","article-title":"A comparison of the effectiveness of topical tetracycline, benzoyl-peroxide gel\u00a0and oral oxytetracycline in the treatment of acne","volume":"16","author":"Norris","year":"1991","journal-title":"Clin Exp\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib98","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/archderm.1976.01630350071017","article-title":"Safety of long-term tetracycline therapy for acne","volume":"112","author":"Sauer","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archderm.1976.01630280009002","article-title":"High-dose tetracycline therapy in severe acne","volume":"112","author":"Baer","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archderm.1970.04000040057011","article-title":"Double-blind study of\u00a0doxycycline in acne vulgaris","volume":"101","author":"Plewig","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib101","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2230.1988.tb00689.x","article-title":"A comparison of doxycycline and minocycline in\u00a0the treatment of acne vulgaris","volume":"13","author":"Harrison","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib102","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib103","first-page":"339","article-title":"Minocycline in acne vulgaris: a double-blind study","volume":"19","author":"Hersle","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.jaad.2006.08.048_bib104","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2340\/00015555-70534537","article-title":"A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris","volume":"70","author":"Sheehan-Dare","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.08.048_bib105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0190-9622(85)70064-3","article-title":"An accurate photographic method for grading acne: initial use in a double-blind clinical comparison of minocycline and tetracycline","volume":"12","author":"Samuelson","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib106","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1001\/jama.1985.03360200082032","article-title":"Minocycline-associated tooth discoloration in young adults","volume":"254","author":"Poliak","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2006.08.048_bib107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2133.1996.tb06972.x","article-title":"Safety of long-term high-dose minocycline in the treatment of acne","volume":"134","author":"Goulden","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib108","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0190-9622(86)70019-4","article-title":"Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study","volume":"14","author":"Gammon","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib109","first-page":"273","article-title":"Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris","volume":"9","author":"Al-Mishari","year":"1987","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2006.08.048_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2001.tb00077.x","article-title":"Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris","volume":"28","author":"Parsad","year":"2001","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib111","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archderm.1975.01630200057005","article-title":"Clindamycin vs placebo as adjunctive therapy in moderately severe acne","volume":"111","author":"Christian","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib112","first-page":"698","article-title":"Clindamycin as an alternative to tetracycline in severe acne vulgaris","volume":"210","author":"Cunliffe","year":"1973","journal-title":"Practitioner"},{"key":"10.1016\/j.jaad.2006.08.048_bib113","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archderm.1976.01630310036007","article-title":"Acne vulgaris: double-blind trial comparing tetracycline and clindamycin","volume":"112","author":"Poulos","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib114","first-page":"109","article-title":"Acne treatment: a comparative efficacy trial of clindamycin and tetracycline","volume":"19","author":"Panzer","year":"1977","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib115","first-page":"424","article-title":"Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg\/day in the treatment of acne vulgaris","volume":"26","author":"Stoughton","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1742-1241.1972.tb04388.x","article-title":"Trimethoprim-sulphamethoxazole versus placebo in acne vulgaris","volume":"26","author":"Macdonald","year":"1972","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.jaad.2006.08.048_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000252042","article-title":"Trimethoprim-sulphamethoxazole in acne vulgaris. A double-blind study","volume":"145","author":"Hersle","year":"1972","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.08.048_bib118","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2133.1971.tb14233.x","article-title":"A\u00a0comparison of trimethoprim-sulphamethoxazole with oxytetracycline in acne vulgaris","volume":"84","author":"Cotterill","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2133.1982.tb00342.x","article-title":"Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris","volume":"107","author":"Gibson","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000247241","article-title":"Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris","volume":"187","author":"Bottomley","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.048_bib121","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/38.5.829","article-title":"Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts","volume":"38","author":"Miller","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2006.08.048_bib122","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib123","first-page":"286","article-title":"The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris","volume":"43","author":"Olson","year":"1998","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.jaad.2006.08.048_bib124","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2006.08.048_bib125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of\u00a0levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2006.08.048_bib127","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.048_bib128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1067\/mob.2003.294","article-title":"A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris","volume":"188","author":"Rosen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2006.08.048_bib129","first-page":"123","article-title":"Superiority of\u00a0a\u00a0combined contraceptive containing drospirenone to a\u00a0triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2005.07.010","article-title":"Treating acne with oral contraceptives: use of lower doses","volume":"73","author":"Huber","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2006.08.048_bib131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib132","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib133","first-page":"84","article-title":"Spironolactone and cimetidine in treatment of acne","volume":"68","author":"Hatwal","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.08.048_bib134","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.291.6504.1231","article-title":"Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment","volume":"291","author":"Greenwood","year":"1985","journal-title":"Br Med J (Clin\u00a0Res Ed)"},{"key":"10.1016\/j.jaad.2006.08.048_bib135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.1986.tb04880.x","article-title":"Anti-androgen treatment in women with acne: a controlled trial","volume":"114","author":"Miller","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib136","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(90)90106-6","article-title":"Cyproterone acetate\/ethinyl estradiol in the treatment of acne. A comparative dose-response study of the estrogen component","volume":"42","author":"Fugere","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.jaad.2006.08.048_bib137","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0190-9622(84)70161-7","article-title":"Acne and hyperandrogenism: impact of lowering androgen levels with glucocorticoid treatment","volume":"11","author":"Nader","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib138","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in\u00a0the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib139","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0190-9622(82)70066-0","article-title":"Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion","volume":"6","author":"Goldstein","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1982.tb00410.x","article-title":"A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population","volume":"107","author":"King","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib141","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(82)70063-5","article-title":"Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study","volume":"6","author":"Peck","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib142","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(82)80055-8","article-title":"Changes in long-term sebum production from isotretinoin therapy","volume":"6","author":"Strauss","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib143","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1983.tb03973.x","article-title":"A dose-response study of I3-cis-retinoic acid in acne vulgaris","volume":"108","author":"Jones","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib144","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a\u00a0multicenter\u00a0dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1985.tb05775.x","article-title":"Isotretinoin and tetracycline in the management of severe nodulocystic acne","volume":"24","author":"Lester","year":"1985","journal-title":"Int J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib146","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000248038","article-title":"Isotretinoin and acne\u2014a study of relapses","volume":"180","author":"Chivot","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.08.048_bib147","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2133.1993.tb11849.x","article-title":"Isotretinoin for acne vulgaris\u201410 years later: a safe and successful treatment","volume":"129","author":"Layton","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib148","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000247322","article-title":"Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years","volume":"186","author":"Lehucher-Ceyrac","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.048_bib149","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1993.tb11850.x","article-title":"Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?","volume":"129","author":"Stainforth","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2133.1997.17771864.x","article-title":"Treatment of acne with intermittent isotretinoin","volume":"137","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib151","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mjd.2001.115965","article-title":"A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne","volume":"45","author":"Strauss","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib152","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archderm.1991.01680030061007","article-title":"An observational study of isotretinoin recipients treated for acne in a health maintenance organization","volume":"127","author":"McElwee","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib153","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mjd.2001.115966","article-title":"Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne:\u00a0A\u00a0randomized trial comparing micronized isotretinoin with standard isotretinoin","volume":"45","author":"Strauss","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib154","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2006.08.048_bib155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0190-9622(92)70088-W","article-title":"Epidemiology of isotretinoin exposure during pregnancy","volume":"26","author":"Dai","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib156","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archderm.1983.01650360033009","article-title":"Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study","volume":"119","author":"Zech","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib157","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198510173131604","article-title":"Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne","volume":"313","author":"Bershad","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2006.08.048_bib158","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archderm.135.8.961","article-title":"Bone densities in patients receiving isotretinoin for cystic acne","volume":"135","author":"Leachman","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib159","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaad.2004.02.012","article-title":"American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations","volume":"50","author":"Goldsmith","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib160","first-page":"171","article-title":"Self-esteem and social assertiveness in patients receiving isotretinoin treatment for cystic acne","volume":"41","author":"Myhill","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.08.048_bib161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(87)70166-2","article-title":"Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin","volume":"17","author":"Rubinow","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib162","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1991.tb00350.x","article-title":"Treatment of the depressed and dysmorphophobic acne patient","volume":"16","author":"Hull","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib163","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib164","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"24","author":"Marqueling","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2006.08.048_bib165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to\u00a0severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib166","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018130","article-title":"Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients","volume":"198","author":"Lehucher-Ceyrac","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.08.048_bib167","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archderm.134.3.376","article-title":"Recurrence rates after the first course of isotretinoin","volume":"134","author":"White","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib168","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archderm.1983.01650300034012","article-title":"Intralesional corticosteroids in the\u00a0treatment of nodulocystic acne","volume":"119","author":"Levine","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib169","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/1523-1747.ep12292717","article-title":"Intralesional triamcinolone and adrenal suppression in acne vulgaris","volume":"57","author":"Potter","year":"1971","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1524-4725.1999.08251.x","article-title":"Glycolic acid versus Jessner's solution: which is better for facial acne patients? A\u00a0randomized prospective clinical trial of split-face model therapy","volume":"25","author":"Kim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.08.048_bib171","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1524-4725.1997.tb00003.x","article-title":"The effect of glycolic acid on the treatment of acne in Asian skin","volume":"23","author":"Wang","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.08.048_bib172","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.08.048_bib173","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2133.1991.tb14751.x","article-title":"Ablation of whiteheads by cautery under topical anaesthesia","volume":"125","author":"Pepall","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.08.048_bib174","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5694\/j.1326-5377.1990.tb126150.x","article-title":"A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne","volume":"153","author":"Bassett","year":"1990","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2006.08.048_bib175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-8741(95)01309-1","article-title":"Comparative efficacy of four Ayurvedic formulations in the treatment of acne vulgaris: a\u00a0double-blind randomised placebo-controlled clinical evaluation","volume":"49","author":"Paranjpe","year":"1995","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jaad.2006.08.048_bib176","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-8741(01)00323-3","article-title":"Clinical trials of ayurvedic formulations in the treatment of acne vulgaris","volume":"78","author":"Lalla","year":"2001","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jaad.2006.08.048_bib177","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1353\/pbm.1973.0048","article-title":"Hypotheses toward a unified field theory of human behavior with clinical application to acne vulgaris","volume":"16","author":"Ellerbroek","year":"1973","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.jaad.2006.08.048_bib178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-3999(83)90021-1","article-title":"Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery","volume":"27","author":"Hughes","year":"1983","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jaad.2006.08.048_bib179","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.3.5558.153","article-title":"Sugar consumption in acne\u00a0vulgaris and seborrhoeic dermatitis","volume":"3","author":"Bett","year":"1967","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2006.08.048_bib180","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1001\/jama.1969.03160370055011","article-title":"Effect of chocolate on acne vulgaris","volume":"210","author":"Fulton","year":"1969","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206023462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206023462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:11Z","timestamp":1759269911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206023462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":180,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0190962206023462"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.048","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines of care for acne vulgaris management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}